Additionally, while a benefit of GLP-1s has generally shown positive cardiovascular outcomes data (less heart attacks, less strokes, less cardiovascular death), I predict that this benefit wont be there if patients have sarcopenic obesity, said Kumar
Understanding this connection can be helpful, as hair loss may not be a direct result of the medication
"It feels like we're all on an island and Big Pharma has the only food source, and they're letting everyone who can't afford it starve." Industry groups that represent compounding pharmacies and suppliers have sued to continue selling these drugs
Participants were randomized to receive either orforglipron or placebo for 52 weeks after stopping their injectable medication
The money question lingers uncomfortably
Nine months: Weight loss continues but tends to slow down, potentially even plateauing for a while